Quantcast Jay La Forest's Pharmacy News
Jay La Forest's Pharmacy News By MRI-BWIMRINETWORK
Pharmacy News and the products and services that drive it forward.
Jay La Forest's Pharmacy News >> PHARMACEUTICAL INDUSTRY December 03, 2008 members login here
>>  PHARMACEUTICAL INDUSTRY
GSK jobs axe bites deeper
The Scotsman - 53 Minutes ago
DRUGS giant GlaxoSmithKline yesterday swung the axe, cutting 200 jobs at a factory in the north-east of England. The job losses at the firm's Barnard Castle site in County Durham were 'worse than expected'.
     Add Comment

ELI LILLY FILES SUIT AGAINST INDIAN PHARMA COS LUPIN, AUROBINDO
TradingMarkets - 57 Minutes ago
(AsiaPulse via COMTEX) -- LLY | Quote | Chart | News | PowerRating -- US-based pharma giants Eli Lilly and company has filed a case against two Indian drug makers, Aurobindo Pharma (BSE:524804) and Lupin
     Add Comment

Novartis malaria drug safe and effective-US FDA panel
Reuters - 5 Hours ago
SILVER SPRING, Md., Dec 3 (Reuters) - Swiss drugmaker Novartis AG's (NOVN.VX: Quote, Profile, Research, Stock Buzz) (NVS.N: Quote, Profile, Research, Stock Buzz) widely-used malaria drug Coartem appears
UPDATE 2-U.S. FDA advisers back Novartis malaria drug CNBC
U.S. FDA panel backs Novartis malaria drug Forbes.com
all 9 news articles >>      Add Comment

MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
Forbes.com - 2 Hours ago
HomeBusiness Tech Markets Entrepreneurs Leadership Personal Finance ForbesLife Lists Opinions Video Blogs E-mail Newsletters People Tracker Portfolio Tracker Special Reports Commerce Energy Health Care
Cytokinetics to Present at the RBC Capital Markets Healthcare Conference TMC Net
Avigen to Present At RBC Capital Markets Healthcare Conference Interest!ALERT
all 19 news articles >>      Add Comment

UPDATE 2-Allergan drug lengthens eyelashes -US FDA staff
CNBC - 4 Hours ago
By Lisa Richwine WASHINGTON, Dec 3 (Reuters) - A drug from Botox maker Allergan Inc increased the length, thickness and darkness of eyelashes in a company study, U.S. drug reviewers said in a report released
Allergan drug lengthens eyelashes -US FDA staff Forbes.com
Allergan Drug Enhances Eyelashes Wall Street Journal Online
all 9 news articles >>      Add Comment

WDT supervisor files lawsuit against police
Elizabethtown Chronicle - 62 Minutes ago
iles lawsuit against police Snyder, campaign manager suing former NWRPD chief and two officers A West Donegal Township supervisor and his campaign manager are suing a former chief and two officers from
Cephalon and Eurand file lawsuit against Mylan and Barr Pharmaceuticals Pharmaceutical Business Review
Discrimination lawsuit filed against Oakland University Daily Tribune
all 12 news articles >>      Add Comment

Memory Pharmaceuticals Receives NASDAQ Decisions
Forbes.com - 113 Minutes ago
MONTVALE, N.J., Dec. 3 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that, on December 3, 2008, the Company received notification from the NASDAQ Listing Qualifications
     Add Comment

Jefferies cutting jobs and closing offices
Reuters UK - 2 Hours ago
(Reuters) - Middle market investment bank Jefferies Group (JEF.N: Quote, Profile, Research) will slash nearly 15 percent of its employees worldwide and close offices in Dubai, Singapore and Tokyo as it
(11/21) AstraZeneca to cut jobs and close three European plants Hematology & Oncology News
all 1 news articles >>      Add Comment

FDA to review Advanced Life Sciences drug
CNBC - 5 Hours ago
CHICAGO - Advanced Life Sciences Holdings Inc. said Wednesday the Food and Drug Administration accepted its application for an antibiotic that treats a form of pneumonia. The company said the FDA set
BRIEF-Advanced Life says FDA accepts NDA for pneumonia drug Forbes.com
FDA accepts filing of Advanced Life Sciences' Cethromycin NDA to treat community RTTNews.com
all 6 news articles >>      Add Comment

Battle The Bear: Big Pharma
CNBC - 105 Minutes ago
Sectors:Pharmaceuticals and Biotechnology Companies:Bristol-Myers Squibb Co | Merck & Co Inc | Celgene Corp | Wyeth | Pfizer Inc | Mentor Corp | Johnson and Johnson The health care has been one of
     Add Comment

Sanofi-Aventis Cutting US Sales Force By Less Than 10%
CNN Money - 5 Hours ago
Sanofi-Aventis (SNY) is reducing its U.S. sales force by less than 10%, continuing a series of layoffs of sales representatives in the beleaguered pharmaceutical industry. The Paris-based drug maker said
Sanofi-Aventis Cutting US Sales Force By Less Than 10% (DJ) Easy Bourse
Sanofi-Aventis Cutting US Sales Force By Less Than 10% >SNY Wall Street Journal Online
all 2 news articles >>      Add Comment

GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs
Forbes.com - 3 Hours ago
LONDON and PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline (LSE/NYSE: GSK) announced today that it is waiving a condition relating to a pending lawsuit in the previously announced tender
     Add Comment

BRIEF-GlaxoSmithKline says waiving condition related to lawsuit in Genelabs offer
Forbes.com - 3 Hours ago
Dec 3 (Reuters) - GlaxoSmithKline PLC: * Says waiving condition relating to pending lawsuit in tender offer to buy Genelabs Technologies (nasdaq: GNLB - news - people ) (For more news, please click here)
GlaxoSmithKline waives condition relating to pending lawsuit in tender offer for RTTNews.com
all 1 news articles >>      Add Comment

BRIEF-Enzon Pharmaceuticals says to purchase part of its senior notes
Forbes.com - 3 Hours ago
Dec 3 (Reuters) - Enzon Pharmaceuticals Inc: * Says to purchase part of its 4% convertible senior notes due 2013 * Says will utilize $100 million of current cash for the tender (For more news, please
BRIEF-Enzon Pharmaceuticals says to purcha... Hemscott
all 1 news articles >>      Add Comment

Next Generation RNAi Technology Discovered by AiRNA Pharmaceuticals and Boston Biomedical...
Forbes.com - 5 Hours ago
AiRNA Pharmaceuticals, Inc., a RNAi therapeutics company based on next generation proprietary RNAi technologies, and Boston Biomedical, Inc., a biotechnology company developing novel therapies targeting
Next Generation RNAi Technology Discovered by AiRNA Pharmaceuticals and Boston Biomedical Pharma Live
Next-Generation Noninvasive Diagnostic Technology Shown To Accurately Detect Fetal Medical News Today
all 3 news articles >>      Add Comment

Merck Vaccine's Side Effects Uncommon: Study
CNBC - 12/3/2008
Mike Huckman CNBC Pharmaceuticals ReporterA first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome. Australian researchers
     Add Comment

Titan Pharmaceuticals Announces Board Decision to Delist Common Stock and Deregister
Forbes.com - 106 Minutes ago
Titan Pharmaceuticals, Inc. (AMEX:TTP) today announced that its Board of Directors has determined to delist and deregister the common stock as part of its previously announced plan to reduce expenses
     Add Comment

Wall Street girds for Merck's 2009 profit forecast
Reuters - 5 Hours ago
By Ransdell Pierson NEW YORK (Reuters) - Merck & Co (MRK.N: Quote, Profile, Research, Stock Buzz), which recently tempered its long-range earnings predictions, is slated on Thursday to forecast its full-year
     Add Comment

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment
MarketWatch - 3 Hours ago
(MARKET WIRE via COMTEX) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California
Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment Yahoo! Canada
Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment Yahoo! Canada
all 2 news articles >>      Add Comment

Brand-name drugs no better than generics
Business Times Singapore - 4 Hours ago
(WASHINGTON) There is no evidence that brand- name drugs given to treat heart and other cardiovascular conditions work any better than their cheaper generic counterparts, US researchers said on Tuesday.
Brand-Name Drugs Do Not Appear Superior to Generic Drugs for Treating Cardiovascular Drugs.com
Brand-name drugs no better than generics: study Reuters Canada
all 22 news articles >>      Add Comment

Lipitor Moves to Preferred Brand Status on CIGNA's Prescription Drug List
Forbes.com - 8 Hours ago
CIGNA Pharmacy Management (CIGNA) has moved Lipitor(R), the world's number one selling drug, to the less expensive preferred brand on the company's prescription drug list. Moving Lipitor to a preferred
Lipitor Moves to Preferred Brand Status on CIGNAs Prescription Drug List DiGiTAL50
Lipitor Moves to Preferred Brand Status on CIGNAs Prescription Business Wire via MSN Money
all 2 news articles >>      Add Comment

Drug companies celebrate collapse of case
The Times - 2 Hours ago
The Serious Fraud Office suffered a huge defeat yesterday with the collapse of its 25 million, six-year investigation into alleged price fixing among drugs manufacturers. The Court of Appeal in London
     Add Comment

Celgene Corporation and Acceleron Pharma to Present ACE-011 Data at the 50th Annual
Forbes.com - 12 Hours ago
Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that
     Add Comment

Geron Announces Initiation of Phase I Clinical Trial of Vaccine Candidate Targeting
Forbes.com - 12 Hours ago
Geron Corporation (Nasdaq:GERN) announced today that its collaborator, Merck & Co., Inc., has initiated a Phase I clinical trial of V934/V935, a non-dendritic cell based cancer vaccine candidate targeting
Geron Announces Initiation of Phase I Clinical Trial of Vaccine Business Wire via MSN Money
Geron reveals initiation of Phase I clinical trial of V934/V935 cancer vaccine candidate RTTNews.com
all 4 news articles >>      Add Comment

AstraZeneca benefits from hunt for defensive stocks
Guardian Unlimited - 8 Hours ago
Defensive stocks such as pharmaceuticals were back in favour as the market shook off early losses and more gloomy economic news to close higher for the second day running. AstraZeneca added 133p to £26.08,
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.